Videos Library
Panel discussion: Capability development for market access: Which competencies are needed in order to be successful?
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Capabilities & Effectiveness
Overview
- Which skills are required from patient access professionals today and tomorrow? Re-tooling your team to maximise performance.
- Which new capabilities do payers and HTAs need to develop in order to evaluate and negotiate next generation therapies?
- How can market access add value to cross-functional teams?
- Implementing capabilities development programs and trainings.
- Internal stakeholder perspective on MA capability development: What are the needs and expectations of internal functions?
Panelists
Sune Lindgaard
Head of Section, Health Economics
Amgros, Pharmaceutical Procurement Service for Regional Authorities, Denmark
Adam Plich
Former Vice President, Pricing & Market Access Europe
Teva Specialty Medicines, Netherlands
François Lucas
Principal Consultant
Huron Consulting Group, UK
Michael Ermisch
Specialist, Pharmaceuticals Department
GKV-Spitzenverband, Germany
Frank Cousins
Senior Director
Valid Insight. UK
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.